Susquehanna International Group, LLP Ligand Pharmaceuticals Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$82.7 - $110.11 $1.77 Million - $2.36 Million	-21,400 Reduced 61.32%	13,500 $1.35 Million
Q2 2024 Aug 15, 2024	SELL	$68.53 - $87.91 $1 Million - $1.28 Million	-14,600 Reduced 29.49%	34,900 $2.94 Million
Q1 2024 May 07, 2024	BUY	$68.64 - $89.2 $1.95 Million - $2.53 Million	28,400 Added 134.6%	49,500 $3.62 Million
Q4 2023 Feb 14, 2024	SELL	$49.57 - $72.63 $470,915 - $689,985	-9,500 Reduced 31.05%	21,100 $1.51 Million
Q3 2023 Nov 14, 2023	SELL	$58.86 - $72.67 $153,036 - $188,942	-2,600 Reduced 7.83%	30,600 $1.83 Million
Q2 2023 Aug 11, 2023	SELL	$69.53 - $79.33 $514,522 - $587,042	-7,400 Reduced 18.23%	33,200 $2.39 Million
Q1 2023 May 16, 2023	BUY	$65.67 - $77.08 $2.07 Million - $2.43 Million	31,500 Added 346.15%	40,600 $2.99 Million
Q4 2022 Feb 14, 2023	SELL	$61.72 - $96.74 $3.01 Million - $4.71 Million	-48,700 Reduced 84.26%	9,100 $607,000
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $298 - $3.21 Million	29,800 Added 106.43%	57,800 $4.98 Million
Q2 2022 Aug 15, 2022	SELL	$74.52 - $117.06 $506,736 - $796,008	-6,800 Reduced 19.54%	28,000 $2.5 Million
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $4.63 Million - $7.38 Million	-48,700 Reduced 58.32%	34,800 $3.92 Million
Q4 2021 Feb 14, 2022	BUY	$127.69 - $165.85 $1.06 Million - $1.38 Million	8,300 Added 11.04%	83,500 $12.9 Million
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $5.35 Million - $7.57 Million	-52,300 Reduced 41.02%	75,200 $10.5 Million
Q2 2021 Aug 11, 2021	BUY	$113.03 - $155.64 $124,333 - $171,203	1,100 Added 0.87%	127,500 $16.7 Million
Q1 2021 May 17, 2021	BUY	$99.52 - $215.83 $2.23 Million - $4.83 Million	22,400 Added 21.54%	126,400 $19.3 Million
Q4 2020 Feb 16, 2021	BUY	$80.55 - $106.05 $5.98 Million - $7.87 Million	74,200 Added 248.99%	104,000 $10.3 Million
Q3 2020 Nov 16, 2020	SELL	$89.56 - $126.72 $1.86 Million - $2.64 Million	-20,800 Reduced 41.11%	29,800 $2.84 Million
Q2 2020 Aug 14, 2020	SELL	$68.28 - $123.65 $4.7 Million - $8.52 Million	-68,900 Reduced 57.66%	50,600 $5.66 Million
Q1 2020 May 15, 2020	SELL	$63.37 - $107.88 $4.52 Million - $7.69 Million	-71,300 Reduced 37.37%	119,500 $8.69 Million
Q4 2019 Feb 14, 2020	BUY	$96.94 - $113.59 $6.06 Million - $7.1 Million	62,500 Added 48.71%	190,800 $19.9 Million
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $10.5 Million - $14.7 Million	-122,100 Reduced 48.76%	128,300 $12.8 Million
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $6.74 Million - $8.12 Million	-62,800 Reduced 20.05%	250,400 $28.6 Million
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $3.26 Million - $4.39 Million	30,800 Added 10.91%	313,200 $39.4 Million
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $21.9 Million - $46.5 Million	171,000 Added 153.5%	282,400 $38.3 Million
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $19.9 Million - $25.8 Million	94,100 Added 543.93%	111,400 $30.6 Million
Q2 2018 Aug 14, 2018	BUY	$150.77 - $207.98 $1.61 Million - $2.23 Million	10,700 Added 162.12%	17,300 $3.58 Million
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $277,260 - $365,240	2,000 Added 43.48%	6,600 $1.09 Million
Q4 2017 Feb 14, 2018	SELL	$128.36 - $147.04 $731,652 - $838,128	-5,700 Reduced 55.34%	4,600 $630,000
Q3 2017 Nov 14, 2017	BUY	$120.91 - $137.94 $1.25 Million - $1.42 Million	10,300	10,300 $1.4 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account